Jian Cao

1.5k total citations
37 papers, 817 citations indexed

About

Jian Cao is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Jian Cao has authored 37 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 20 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Jian Cao's work include Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (10 papers) and RNA modifications and cancer (8 papers). Jian Cao is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (10 papers) and RNA modifications and cancer (8 papers). Jian Cao collaborates with scholars based in China, Hong Kong and United States. Jian Cao's co-authors include Pengfei Xu, Dake Li, Chencheng Dai, Xuemei Jia, Sujuan Xu, Lianmei Zhao, Ziyi Fu, Bo Gao, Xuhua Hu and Ran Dong and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Analytical Chemistry.

In The Last Decade

Jian Cao

35 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian Cao China 19 589 382 97 79 59 37 817
Yi Lei China 13 391 0.7× 278 0.7× 49 0.5× 156 2.0× 84 1.4× 45 704
Jing Mo China 15 634 1.1× 298 0.8× 160 1.6× 91 1.2× 49 0.8× 66 1.0k
José Rojas Colombia 10 626 1.1× 190 0.5× 115 1.2× 144 1.8× 39 0.7× 18 992
Nuria Martí Gutiérrez Spain 9 633 1.1× 152 0.4× 154 1.6× 65 0.8× 40 0.7× 13 846
Geert Michel Germany 10 533 0.9× 168 0.4× 49 0.5× 76 1.0× 36 0.6× 22 718
Huei San Leong Australia 9 390 0.7× 131 0.3× 90 0.9× 108 1.4× 66 1.1× 11 686
Xiuli Wang China 16 337 0.6× 304 0.8× 53 0.5× 62 0.8× 43 0.7× 35 544
Michelle Moksa Canada 16 518 0.9× 194 0.5× 166 1.7× 69 0.9× 22 0.4× 35 734

Countries citing papers authored by Jian Cao

Since Specialization
Citations

This map shows the geographic impact of Jian Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Cao more than expected).

Fields of papers citing papers by Jian Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Cao. The network helps show where Jian Cao may publish in the future.

Co-authorship network of co-authors of Jian Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Cao. A scholar is included among the top collaborators of Jian Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Cao. Jian Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Fangfang, Lin Gan, Guiping Wan, et al.. (2025). Serum 2-miRNA panel as a non-invasive diagnostic biomarker for adenomyosis. Gene. 970. 149777–149777.
2.
Wan, Xufeng, et al.. (2025). Single-cell RNA sequencing reveals immune regulatory mechanisms and molecular therapeutic strategies in the microenvironment of multiple myeloma. International Journal of Surgery. 112(1). 333–351. 1 indexed citations
3.
Cao, Jian, Huan Wang, Jing Yang, et al.. (2023). Exosome-transmitted miR-30a-5p enhances cell proliferation, migration, and invasion in ovarian cancer. Cell Division. 18(1).
4.
Cao, Jian, et al.. (2023). ICI efficacy information portal: a knowledgebase for responder prediction to immune checkpoint inhibitors. NAR Cancer. 5(1). zcad012–zcad012. 2 indexed citations
5.
Xu, Pengfei, Sujuan Xu, Chencheng Dai, et al.. (2023). Differential effects of the LncRNA RNF157-AS1 on epithelial ovarian cancer cells through suppression of DIRAS3- and ULK1-mediated autophagy. Cell Death and Disease. 14(2). 140–140. 19 indexed citations
6.
Gui, Tao, Ming Liu, Bing Yao, et al.. (2021). TCF3 is epigenetically silenced by EZH2 and DNMT3B and functions as a tumor suppressor in endometrial cancer. Cell Death and Differentiation. 28(12). 3316–3328. 33 indexed citations
7.
Liu, Yi, et al.. (2021). RP11-874J12.4, a novel lncRNA, confers chemoresistance in human gastric cancer cells by sponging miR-3972 and upregulating SSR2 expression.. PubMed. 13(6). 5892–5910. 10 indexed citations
8.
Nong, Wenyan, Jian Cao, Yiqian Li, et al.. (2020). Jellyfish genomes reveal distinct homeobox gene clusters and conservation of small RNA processing. Nature Communications. 11(1). 3051–3051. 53 indexed citations
9.
Zhang, Yan, Xing Zhang, Haixia Zhu, et al.. (2020). <p>Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Recurrence in Patients with Cervical Cancer</p>. Cancer Management and Research. Volume 12. 719–730. 24 indexed citations
10.
Dai, Chencheng, Pengfei Xu, Siyu Liu, et al.. (2020). Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells. Archives of Gynecology and Obstetrics. 303(5). 1271–1281. 22 indexed citations
11.
Wang, Zhu, Yang Li, Jian Cao, et al.. (2020). <p>MicroRNA Profile Identifies miR-6165 Could Suppress Gastric Cancer Migration and Invasion by Targeting STRN4</p>. OncoTargets and Therapy. Volume 13. 1859–1869. 5 indexed citations
12.
Wang, Yuetong, Jian Cao, Weiwei Liu, et al.. (2019). Protein tyrosine phosphatase receptor type R (PTPRR) antagonizes the Wnt signaling pathway in ovarian cancer by dephosphorylating and inactivating β-catenin. Journal of Biological Chemistry. 294(48). 18306–18323. 13 indexed citations
13.
Gao, Bo, Lianmei Zhao, Feifei Wang, et al.. (2019). Knockdown of ISOC1 inhibits the proliferation and migration and induces the apoptosis of colon cancer cells through the AKT/GSK-3β pathway. Carcinogenesis. 41(8). 1123–1133. 8 indexed citations
14.
Zhou, Sisi, Tao Hu, Fen Zhang, et al.. (2019). Integrated Microfluidic Device for Accurate Extracellular Vesicle Quantification and Protein Markers Analysis Directly from Human Whole Blood. Analytical Chemistry. 92(1). 1574–1581. 66 indexed citations
15.
Li, Meng, Lianmei Zhao, Jing Li, et al.. (2018). Differentially expressed lncRNAs and mRNAs identified by NGS analysis in colorectal cancer patients. Cancer Medicine. 7(9). 4650–4664. 35 indexed citations
16.
Lv, Juan, Pengfei Xu, Lin Gu, et al.. (2017). Identification of microRNAs and genes associated with hyperandrogenism in the follicular fluid of women with polycystic ovary syndrome. Journal of Cellular Biochemistry. 119(5). 3913–3921. 47 indexed citations
17.
Wang, Huan, Ziyi Fu, Chencheng Dai, et al.. (2016). LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer. Scientific Reports. 6(1). 38983–38983. 62 indexed citations
18.
Kirov, Stefan, Heshani Desilva, Jian Cao, et al.. (2015). Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression. Molecular Cancer Therapeutics. 14(10). 2167–2174. 72 indexed citations
19.
Lei, Zhe, Hongbing Chen, Jian Cao, et al.. (2015). Inactivation of BLU is associated with methylation of Sp1-binding site of BLU promoter in gastric cancer. International Journal of Oncology. 47(2). 621–631. 5 indexed citations
20.
Cao, Jian, et al.. (2014). MicroRNA-146a and -21 cooperate to regulate vascular smooth muscle cell proliferation via modulation of the Notch signaling pathway. Molecular Medicine Reports. 11(4). 2889–2895. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026